ArticleScientific reports2024

Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells.

Andrew N Hakeem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.